Could an Anti-Seizure Drug Help Prevent Alzheimer’s Disease?
Promising Research Findings
A recent study indicates that a decades-old anti-seizure medication may play a role in slowing the progression of Alzheimer’s disease. This research utilized animal models, human neurons, and brains from individuals at a heightened risk of developing Alzheimer’s.
Mechanism of Action
The study focused on levetiracetam, an established anti-seizure drug, to explore its potential as a treatment for Alzheimer’s. Published in Science Translational Medicine, the paper details a three-pronged investigation that reveals how levetiracetam reduces the accumulation of amyloid-beta proteins, which are associated with Alzheimer’s, in neurons.
Research Results
In experiments involving genetically engineered mice predisposed to amyloid buildup, researchers observed that levetiracetam led to fewer disrupted synapses. This suggests that the drug could mitigate the detrimental effects of protein accumulation in the brain.
Future Implications
Although the journey to repurpose levetiracetam for Alzheimer’s treatment requires extensive further research, the findings provide a hopeful perspective on its underlying mechanism. With estimates suggesting that the number of Alzheimer’s patients in the United States could reach 14 million by 2060 and a lack of effective treatments currently available, this research is likely to prompt further exploration.